Nurturing the stem cell business: lessons from the recombinant drugs markets?

By Junold Robert   Wink Rudiger  

International Journal of Biotechnology, Vol. 8, Iss. 3-4, 2006-03 ,pp. : 187-205

Inderscience Publishers

Access to resources Recommend Favorite

Impact of the life sciences on organisation and management of R&D in large pharmaceutical firms

By Mittra James  

International Journal of Biotechnology, Vol. 10, Iss. 5, 2008-11 ,pp. : 416-440

Inderscience Publishers

Access to resources Recommend Favorite

The commercialisation of biotechnology in Japan: bio-ventures as a mechanism of knowledge transfer from universities

By Lynskey Michael J.  

International Journal of Biotechnology, Vol. 6, Iss. 2-3, 2004-07 ,pp. : 155-185

Inderscience Publishers

Access to resources Recommend Favorite

Tailored recombinant elastin-like polymers for advanced biomedical and nano(bio)technological applications

By Arias F.   Reboto Virginia   Martín Susana   López Isabel   Rodríguez-Cabello J.  

Biotechnology Letters, Vol. 28, Iss. 10, 2006-05 ,pp. : 687-695

Springer Publishing Company

Access to resources Recommend Favorite

Biopharmaceutical production in transgenic livestock

By Rudolph N.S.  

Trends in Biotechnology, Vol. 17, Iss. 9, 1999-09 ,pp. : 367-374

Elsevier

Access to resources Recommend Favorite